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A B S T R A C T
The innate immune system acts in the ﬁrst line of host defense against pathogens. One of the mechanisms
used involves the early recognition and uptake ofmicrobes by host professional phagocytes, through pattern
recognition receptors (PRRs). These PRRs bind to conserved microbial ligands expressed by pathogens and
initiate both innate and adaptative immune responses. Some PRRs located on the surface of dendritic cells
(DCs) and other cells seem to play an important role in human immunodeﬁciency virus type 1 (HIV-1)
transmission. Dendritic cell–speciﬁc intercellular adhesion molecule–3 grabbing non-integrin, CD209 (DC-
SIGN) and its homolog, DC-SIGN-related (DC-SIGNR or L-SIGN) receptors are PPRs able to bind the HIV-1
gp120 envelope protein and, because alterations in their expression patterns also occur, they might play a
role in both horizontal and vertical transmission as well as in disseminating the virus within the host. This
review aims to explore the involvement of the DC-SIGN and L-SIGN receptors in HIV-1 transmission from
mother to child.
 2011 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc.
Open access under the Elsevier OA license.1. Introduction
The Joint United Nations Program on HIV-1/AIDS estimates that
2.1 million children worldwide are infected with human immuno-
deﬁciency virus type 1 (HIV-1) [1] and that more than 430,000
children were newly infected in 2008. Mother-to-child transmis-
sion, also known as vertical transmission, accounts for more than
40% of all HIV-1 infections in children [2] and can occur in three
ways [3–5]: during pregnancy through the placenta (transplacental
or intrauterine transmission); during delivery (intrapartum trans-
mission) through amniotic ﬂuids, infected blood and cervical secre-
tions; and during the process of breastfeeding. In addition, some
independent factors have been associated with vertical transmis-
sion of HIV-1, such as highmaternal viral load, low amount of CD4
T cells, vaginal delivery and lower gestational age [4,5].
Global estimates show that, without speciﬁc medication, the
rate of transmission of HIV-1 from mother to child is around
15–45% [6]; using antiretroviral therapies, this percentage has
sharply dropped to 2%. However, although prophylactic antiretro-
viral therapy can reduce mother-to-child transmission to 2%, the
limited access to timely diagnosis and drugs in many developing
countries reduces the potential impact of this strategy [5]. Despite
the sharp fall in the rate of viral transmission, a signiﬁcant percent-
age of children are still being infected with HIV-1; themechanisms
used by the virus to escape the immune response and infect targets* Corresponding author.
E-mail address: segat@burlo.trieste.it (L. Segat).
0198-8859/11 2011 American Society for Histocompatibility and Immunogenetics. Pub
doi:10.1016/j.humimm.2011.01.012cells of children born to infected mothers treated with antiretrovi-
ral therapies still remain to be clariﬁed.
A better understanding of the immunologic mechanisms act-
ing at the maternal–fetal interface and of host–pathogen inter-
action is essential for the development of alternative interven-
tions aimed to prevent viral transmission. This review aims to
explore the involvement of the dendritic cell–speciﬁc intercel-
lular adhesion molecule–3 grabbing non-integrin, CD209 (DC-
SIGN) and DC-SIGN-related C-type lectin domain family 4, mem-
ber M (L-SIGN) receptors in HIV-1 transmission from mother to
child.
2. DC-SIGN and L-SIGN receptors
The innate immune system is the ﬁrst line of host defense
against pathogens; it involves the early recognition and uptake of
microbes by host professional phagocytes, such as dendritic cells
(DCs) and macrophages, through germline-encoded receptors,
known as pattern recognition receptors (PRRs) [7]. These proteins
bind to conserved microbial ligands expressed by the pathogens,
and initiate both innate and adaptative immune responses. PRRs
are involved in phagocytosis, and antigen presentation could acti-
vate intracellular signaling and cytokine secretion. The efﬁciency of
this initial pathogen recognition may have important conse-
quences in the pathogenesis of infectious diseases [8].
Some PRRs located on the surface of DCs and other cells seem to
play an important role in HIV-1 transmission. Of particular interest
are the DC-SIGN and its close relative, L-SIGN (also known as DC-
SIGN related [DC-SIGNR], CD209L or CLEC4M) receptors [9,10].
lished by Elsevier Inc. Open access under the Elsevier OA license. 
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R. Celerino da Silva et al. / Human Immunology 72 (2011) 305–311306DC-SIGN and L-SIGN receptors, two C-type lectins, are long type
I integral membrane proteins [11,12] that are involved in both
nnate and adaptive immunity [13–15]. They present strong depen-
ence on calcium and act as cellular adhesion’s receptors and are
nvolved in pathogen recognition [16,17]. As pathogen-recognition
eceptors, both these lectins recognize awide range ofmicroorgan-
sms, some of which have a major impact on public health. For
xample, DC-SIGN captures viruses, such as Ebola virus [18], hepa-
itis C virus [19,20], Dengue virus [21], cytomegalovirus [22], and
ARS coronavirus (SARS-CoV) [23,24], bacteria such as Mycobacte-
rium tuberculosis [25] and Helicobacter pylori [26], and parasites
uch as Leishmania pifanoi [27]. L-SIGN is able to capture viruses
uch as Ebola virus [18], hepatitis C virus [19,20,28], and more
Fig. 1. Predicted protein domains in DC-SIGN and L-SIGN.Fig. 2. Schematic representation of tetrameric form of DC-SIGecently SARS-CoV [23,29], as well as bacteria such asM tuberculo-
sis [30], and Leishmania infantum [27]. Both DC-SIGN and L-SIGN
can recognize and capture human immunodeﬁciency virus 1 by
binding to the gp120 glycoprotein [31–35].
DC-SIGN and L-SIGN receptors are organized into three struc-
turally distinct regions (Fig. 1): an intracytoplasmatic tail domain
responsible for internalization and signal transduction [36] that
consists of N-terminal, LL, and YKSL motifs and a triacidic group
(EEA), then a transmembrane domain and ﬁnally an extracellular
domain, which is further divided into two structures, the neck
repeat region and the carbohydrate recognition domain (CRD) [17].
The neck repeat region usually consists of 7 full and 1 incom-
plete tandem repeats of a sequence of 23 highly conserved amino
acids, but the number of repeats can vary in the population: the
neck repeat region of the L-SIGN receptor is highly polymorphic
(4–10 repetitions are often found), while the one of DC-SIGN is less
polymorphic (mainly seven repetitions) [12,17,37]. The neck re-
peats region plays a crucial role in tetramerization and supports
carbohydrates’ recognition, thus directly inﬂuencing the receptor’s
binding afﬁnity to pathogens [8,17,36].
The number of tandem-neck repeats determines the multim-
erization status (Fig. 2). Feinberg et al. [38] showed that the lack of
two repeats (ﬁve-repeat allele) results in partial dissociation of the
ﬁnal tetramer, whereas the lack of even more than ﬁve repeats
causes a reduction in the overall stability of the molecule. By using
a series of recombinant soluble receptors with different number of
repeats, Synder et al. [39] showed that the binding afﬁnity to HIV-1
gp120 glycoprotein was affected by the length of the repeats and
multimerization status, with tetrameric forms presenting a higher
afﬁnity than shorter monomeric forms. The CRD, both in DC-SIGN
and L-SIGN, is ﬂexibly connected to the neck repeat region, allow-
ing a departure from the membrane, which enables the binding of
pathogens in a calcium-dependent manner [36].
DC-SIGN and L-SIGN belong to the CD209 gene family and prob-
ably originated following a gene duplication event [17]. The human
genes encoding DC-SIGN and L-SIGNmap on 19p13.2-3 and extend
approximately for 13 kb [35,40]. In addition, they share the same
introns and exons organization (consisting in seven exons and ﬁve
introns) and the encoded proteins present a high similarity at the
amino acid level (77% identity) [17].
The two receptors are characterized by different expression
atterns. DC-SIGN is highly expressed in monocytes and CD34
monocyte-derived DCs and in subsets of immature andmature DCs
in various tissues such as dermis,mucosa, spleen, placenta (special-N and L-SIGN. CRD, carbohydrate recognition domain.
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R. Celerino da Silva et al. / Human Immunology 72 (2011) 305–311 307ized macrophages of decidua and Hofbauer cells in the chorionic
villi), and lung (specialized macrophages in the alveoli) [36,41,42].
In contrast, L-SIGN is not expressed by DCs or monocyte-derived
DCs in vitro, and its expression is limited to some tissues, such as
lymph nodes (endothelial cells in the subcapsular sinus), liver (si-
nusoidal endothelial cells), placenta (capillary endothelial cells),
lung (alveolar cells and endothelial cells), and intestine (villi capil-
laries in the lamina propria of the terminal ileum, Peyer’s patches)
[12,36].
3. DC-SIGN and L-SIGN interaction with HIV-1
As a speciﬁc adhesion receptor, DC-SIGN mediates the interac-
tion between DCs and T cells by binding with high afﬁnity to
ICAM-3 [9,11]. The interaction between DC-SIGN and ICAM-3 ex-
pressed on T cells contributes to a close interaction between DCs
and T cells required for an efﬁcient antigen presentation. DC-SIGN
can also facilitate the capture of viral antigens by class I and class II
MHC, leading to activation of speciﬁc CD8 and CD4 T cells [36].
The interaction between DC-SIGN and L-SIGN and the HIV-1 has
een alreadywell studied [9,16,32–34,36,39,43–49]. Asmentioned
efore, DC-SIGN can bind to the gp120 protein of HIV-1 [41,42,50]
apturing the virus and possibly increasing HIV-1 transmission
12]. Similar to DC-SIGN, L-SIGN also captures the HIV-1 virus by
inding to the gp120 and promoting the enhancement of T cell
nfection by HIV-1 in trans [17,34]; however, L-SIGN can also inter-
alize the virus and promote virus degradation in a proteasome-
ependent manner, possibly directly affecting the outcome of the
nfection by HIV-1 [5]. The presence of L-SIGN on the surface of
ndothelial cells in lymph node sinuses represents an obvious
echanism by which the virus can be transmitted to CD4 cells
hat trafﬁc into lymph nodes via the afferent lymphatics. In addi-
ion, since L-SIGN binds to ICAM-3 and may bind to other cell
urface receptors, interactions between T-cells and the endothelial
ell surfacemay occurmore frequently, increasing the likelihood of
irus transmission [9].
AlthoughDC-SIGN and L-SIGN are not direct receptors for HIV-1
nfection, they work efﬁciently in the capture of HIV-1 from the
eriphery, thus facilitating viral transmission to secondary lym-
hoid organs rich in T cells and increasing the infection of target
D4 cells [16,32,33].
The HIV-1 virus can infect cells through two different paths: the
rans- and the cis-infection (Fig. 3A, B). Although infection in trans
Fig. 3. Paths of infection by HIV-1. (A) Infection in trans using DC-SIGN receptor in D
B) Infection in cis using DC-SIGN in specialized macrophage.ccurs when DC-SIGN is expressed on a separate cell from the onethat becomes infected, the infection in cismayoccurwhenDC-SIGN
is co-expressed with CD4 and chemokine receptor (e.g., CCR5) on a
permissive cell type, such as macrophages [16,36,40]. Co-expres-
sion of CD4, CCR5, and CXCR4 receptors with DC-SIGN receptor has
been blamed for the increase in the efﬁciency of HIV-1 infection,
suggesting the involvement of the DC-SIGN receptor in viral trans-
mission, besides increasing the efﬁciency of the infection in cis [51].
Both DC-SIGN and L-SIGN receptors are involved in HIV-1 infection
in trans [34]. However, the HIV-1 infection in cis, has only been
observed so far for DC-SIGN receptor.
The interaction of DC-SIGN and L-SIGN molecules with the
HIV-1 occurs through the connection between their CRD with the
gp120 viral envelope glycoprotein [16,17]. Binding of the gp120 to
DC-SIGN and L-SIGN molecules may induce a conformational
change in the gp120 itself that enables a more efﬁcient interaction
with CD4 and/or the chemokine receptor and subsequent mem-
brane fusionwith T cells. Alternatively, the binding of viral particles
to the DCs may increase the probability that entry will occur after
binding to the CD4 and co-receptor complex on target cells [10].
The ability of DC-SIGN and L-SIGN receptors to capture and trans-
mit the HIV-1 to T cells may largely depend on their membrane
organization in rafts or their capability to multimerize [10]. In
addition, alternative splicing events can occur in DC-SIGN e L-SIGN,
leading to the production of a vast repertoire of membrane-bound
and soluble isoforms, which may also differently affect the process
of HIV-1 transmission [5,17,52].
4. DC-SIGN and L-SIGN implications in vertical transmission of
HIV-1
4.1. DC-SIGN and L-SIGN in trans-placental HIV-1 transmission
The human placenta is responsible for a close juxtaposition
between fetal and maternal blood; however, this apparent barrier
is permeable enough to display the HIV-1 from the mother, a fact
that leads to fetal exposure to virus [53]. Thus, the placenta can play
an important role in the transmission ofHIV-1 infection.Most cases
of vertical transmission via uterus occur through of the placenta
(Fig. 4), especially during the third trimester of pregnancy [43]. It is
estimated that the trans-placental or intrauterine HIV-1 transfer
comprise 17–38% of cases of vertical transmission, but little is
known about the mechanisms involved in the transmission of the
virus [54]. Some cell types are pointed out as likely targets for the
ismechanism is very similar to the one used by L-SIGN receptor in endothelial cells.viral spread, such as macrophages present in the decidua and spe-
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R. Celerino da Silva et al. / Human Immunology 72 (2011) 305–311308cializedmacrophages present in the placenta (Fig. 4), also known as
Hofbauer cells [54]. Both decidual macrophages and Hofbauer cells
play important roles in the placental physiology, the ﬁrsts promot-
ing the development and control of blood ﬂow and the latter acting
in the defense against infectious agents (Hofbauer cells) [54].
Hofbauer cells, specialized macrophages from human placenta,
upport infection by HIV-1 both in vitro and in vivo [55]. This ability
o support HIV-1 infection is probably associated with the expres-
ion of some cellular receptors related to the infection of T lympho-
ytes, such as CD4, CCR5, CXCR4, and DC-SIGN, also expressed in
hese cells [54,55]. During pregnancy, there is an increased expres-
ion of DC-SIGN by Hofbauer cells in the chorionic villi, and this
xpression has been correlated with increased rates of HIV-1 ver-
ical transmission [54]. Thus, DC-SIGN can enhance the binding of
IV-1 on the surface of Hofbauer cells, providing an efﬁcientmech-
nism by which the virus can be transmitted to other receivers
ermissible to HIV-1 in trans. Thus, one can wonder: How is the
ontact between native virus-bound infected cells with the fetal
ells expressing receptors for HIV-1?
The main physical barrier between fetal Hofbauer cells and
aternal ﬂuids is thewall of the trophoblast cells; however tropho-
last cells can express receptors for HIV-1 entry, so they can be
nfected by the virus [55]. Moreover, breaches in the wall of the
rophoblasts can originate from spontaneous processes or in con-
Fig. 4. Schematic summary of placental structure and salient features thatmay be in
fetal andmaternal tissues in the placenta. Resident leukocyte populations on both th
cells in chorionic villi and on maternally decidual macrophages. These cell populatiequence of infectious diseases (such as corioamniotite) and be-avioral habits such as smoking and drug use [55,56], allowing a
irect contact between fetal Hofbauer cells DC-SIGN CD4 CCR5
CXCR4 and viral particles adsorbed to thematernal decidual mac-
rophages or DCs expressing DC-SIGN, present in maternal blood
[54,55,57]. Therefore, the contact between maternal and fetal cells
through the wall of the trophoblasts, allows the efﬁcient spreading
of HIV-1 to fetal cells expressing receptors for viral binding and
entry, allowing establishment of the infection [55].
A study has suggested that the mechanism of HIV-1 association
with the cells, such as HIV-1 adsorbed to the DC-SIGN receptor,
operates more efﬁciently in pregnancies where the viremia re-
mains low because of the administration of antiretroviral therapies
[54]. Why does this happen?
Some authors explain that binding of viral particles to DC-SIGN
may focus or concentrate the virus particles at the surface of the DC
and may thus increase the probability that entry will occur after
binding to the CD4 and co-receptor complex on target cells [9]. In
addition, the HIV-1 virus can remain viable for several days on the
DC-SIGN–expressing cell, and then can be more efﬁciently trans-
ferred to T cells than to the transfer executed by free cells [10,16].
For the L-SIGN receptor, this fact is not observed. In addition, some
authors propose three different mechanisms to explain how the
HIV-1 virus is transmitted from mother to child, via the placenta.
The ﬁrst mechanism suggests that Hofbauer cells infected with
d in transplacental transmission of HIV-1. There is an intimate relationship between
andmaternal sides are indicated. DC-SIGN is expressed on fetally derivedHofbauer
e in very close proximity. L-SIGN is expressed on placental capillary endothelium.volveHIV-1 or with the virus adsorbed to their cell membrane through
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bilical vein [54,55]. The second mechanism is that Hofbauer cell
infected by HIV-1 or carrying the virus adsorbed on the surface,
remains in situ in the chorionic villi, promoting HIV-1 antigen
resentation and subsequent T lymphocytes infection. However,
hismechanism seemsunlikely, since T lymphocytes are inconspic-
ous in chorionic villi [54,55]. The third mechanism argues that
ofbauer cells may become infected by HIV-1 and may release
nfectious viral particles,whichmay become adsorbed to L-SIGNon
he immediately adjacent placental capillary endothelium. The en-
othelium may, in turn, mediate infection of HIV-1 receptor–
ositive T-lymphocytes circulating in the blood. Infected T lympho-
ytes or Hofbauer cells either productively infected with HIV-1 or
imply with the virus adsorbed to their surface may then travel
etween the placenta and the fetus in umbilical cord blood
16,54,55].
.2. DC-SIGN and L-SIGN in post-partum HIV-1 transmission
In the intra- and post-partumvertical transmission ofHIV-1, the
irus is delivered and transmitted because of the contact with
mniotic ﬂuid, maternal blood, and cervical secretion (intra-
artum) or with breast milk (post-partum) [3,58].
It has been reported that, in the absence of a prophylactic anti-
etroviral therapy, the breast milk of infected mothers is responsi-
le for more than 40% of cases of children infected with HIV-1 via
ertical transmission [2–4,59]. Some factors, such as the viral load
in the plasma and breast milk may be relevant for vertical trans-
mission of HIV-1 [60].
Transmission of the HIV-1 virus frommother to child via breast
ilk can occur by free virus particles and/or viral particles associ-
ted with cells [4]; in this case, the expression of cellular receptors
or recognition and adhesion of pathogens is required. Among the
ell types involved in the transmission of HIV-1 via breastfeeding,
acrophages and mammary epithelial cells should be mentioned.
reast milk is the only bodily ﬂuid that contains a large number of
acrophages, comprising more than 80% of all cells present in
olostrum [61]. Expressing CCR5,macrophages are prime targets of
he HIV-1 virus, which uses the co-receptors CCR5 for viral entry
4]. In addition, macrophages, derived from peripheral blood
onocytes (PBMo), are present in different concentrations
hroughout lactation, acting as immunoprotective in situ [61].
Moreover, it has been reported that macrophages also express
C-SIGN receptors [61]. In certain situations, the expression levels
f DC-SIGN on macrophages can be quite high, especially when
timulated with interleukin (IL)–4, which also promotes reduction
n the expression of CCR5 and CXCR4, suggesting the need for
hanges in local inﬂammatory Th2 dominance for an acceleration
f HIV-1 transmission via breastfeeding [59–61]. Local production
f IL-4 during infectious processes, as inmastitis, can over-regulate
he expression of DC-SIGN onmacrophages, suggesting the associ-
tion of mastitis with high viral load in breast milk and high risk of
ertical transmission of the virus [61].
Along with the macrophages, mammary epithelial cells may
lso be infected byHIV-1, through the co-receptor CXCR5 [4]. Some
tudies suggest the possibility of a HIV-1 compartmentalization
etween blood and milk, suggesting that the virus could be pro-
uced in and transmitted by the milk, through the mammary epi-
helial cells. In this sense, the viruses that derived from mammary
pithelial cells can determine the tropism of HIV-1 transmitted to
ells located in the gastrointestinal tract [60].
After being introduced in the organism through infected breast
ilk, the virus reach the mucosa of the upper intestine, where, in
he lamina propria, a large pool of lymphocytes expressing CCR5
nd CXCR4 facilitate viral replication. The presence of DCs express-
ng a series of receptors, such as CD4/CCR5, DC-SIGN, and DC206, tas been reported in the human gut [58]. From the mucosa, the
irus is systemically spread and produces a profound depletion of
D4 T cells, with monocytes and macrophages also acting as
ellular reservoirs for HIV-1 [3]. The viral entry through themucosa
f the gastrointestinal tract can be mediated by the binding of the
C-SIGN receptor, expressed on DCs, to the viral gp120 protein [2].
his interaction appears to bemore pronounced in the tonsils at the
op of the esophagus and intestinal tract [4].
The infectivity of viruses associated with cells and captured by
C-SIGN is stable even in presence of the acidiﬁcation process
ccurring in the gastrointestinal tract, suggesting that the virus
ound to DCs through DC-SIGN is protected from the action of the
astric juice. The fact that the free viral particles loose their infec-
ivitywhen exposed to acidic environments, suggest that the trans-
ission of the virus to free cells inmilk is hampered by gastric juice
60]. However, it is possible that free cells become infected in the
ral mucosa and esophagus, where the acidity is not high. Studies
ith Raji cells expressing DC-SIGN, preincubated with PBS and
ith the HIV-1 virus, showed an efﬁcient viral transfer. However,
aji cells expressing DC-SIGN, incubated with HIV-1 virus and
ninfected humanmilk, showed a signiﬁcant reduction of the bind-
ng of HIV-1 gp120 to DC-SIGN receptor. This suggests that in
uman milk some factors that could prevent the interaction be-
ween the gp120 and DC-SIGN receptor exist [4].
Similar tests were conducted for L-SIGN receptor, however,
reast milk did not inhibit the interaction between the viral pro-
eins and the receptor, suggesting that L-SIGN receptor can be used
y the virus to increase its infectivity [4]. Some studies also report
hat exclusive feeding with uninfected mothers’ milk during the
rstmonths of life protects against a variety of infections, including
IV-1, and help ﬁght morbidity and mortality, suggesting that
here should be certain components in the human milk that may
rotect against the transmission of the virus [59]. So,what are these
ikely factors in breast milk, and how do they act in protection
gainst the infection caused by HIV-1?
Breast milk is provided with a series of antimicrobial com-
ounds, such as lactoferrin, lysozyme, secretory leukocyte protease
nhibitor, lactodifucotetrase, lacto-N-fucopentose I, II, and III, and
onofucosilacto-N-hexose III, among others, which are associated
ith a reduced rate of HIV-1 transmission [2,59]. Some studies
ttribute this reduction in viral transmission to certain antigens,
uch as Lewis structures, which compete with the gp120 for a
inding site in the DC-SIGN receptor, inhibiting the viral transfer to
D4 T cells [2]. Inhibition of the binding between gp120 and
DC-SIGN receptor is probably due to the size of the compound,
which contains many Lewis structures that mask the interaction
sites [4]. Compounds containing Lewis structures and present in
breast milk were shown to interact with DC-SIGN, blocking the
response of Th1 cells and resulting in an increased responsiveness
of Th2 cells, suggesting that these compounds may inﬂuence the
immune response by acting as immunomodulatory factors [4]. A
constituent of human milk, bile salt-stimulated lipase, a Lewis X
(Lex)–containing glycoprotein secreted by the pancreas as well as
by mammary gland, has been shown to inhibit DC-SIGN binding to
HIV andDC-SIGN-mediated transfer ofHIV-1 toCD4 lymphocytes,
by competing with the virus for the binding to DC-SIGN [62]. The
binding of bile salt-stimulated lipase to DC-SIGN can be prevented
using an antibody against Lex, thus demonstrating the importance
of the Le [10] epitope.
Others constituents of human milk, such as human milk oligo-
accharides and MUC1 (epithelial mucin), have shown promising
esults and could be used to develop drugs that inhibit the HIV-1
inding to DC-SIGN [2,59]. Hong et al. [2] found a reduction ofmore
han60% in the interactionbetweengp120 and the receptor protein
C-SIGN when using human milk oligosaccharides at a concentra-
ion of 0.5 g/l, the one usually present in breast milk. Additionally,
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R. Celerino da Silva et al. / Human Immunology 72 (2011) 305–311310Saeland et al. [59] also described the blocking of the interaction
etween the gp120 and DC-SIGN receptor in the presence of MUC1
actor, present in human milk. Because of the blockade, there was
he prevention of the virus transmission to CD4 T cells.
Blocking DC-SIGNmay be a double-edged sword. It may reduce
he entrance of certain viruses, such as HIV-1, but at the same time
t may also reduce the ability of the infant’s immune system to
etect and ﬁght other pathogens [2].
. Polymorphisms in DC-SIGN and L-SIGN genes and vertical
ransmission of HIV-1
For some genes, susceptibility and/or resistance to certain (in-
ectious but not only) diseases has been associated with gene ex-
ression levels andwith the presence of gene variations/mutations.
an this happen also for DC-SIGN and L-SIGN? Can variations in the
ene encoding DC-SIGN and L-SIGN be associated with vertical
ransmission of HIV-1?
To date, except one study regarding the L-SIGN gene, no other
enetic studies trying to associatemutations in the genes encoding
or DC-SIGN and L-SIGNwith the vertical transmission of the HIV-1
ave been performed. Boily-Larouche et al. [5] performed an asso-
iation study in a well-characterized cohort of 197 HIV-1–infected
others and their children from Zimbabwe, and found that chil-
ren with two copies of H1 and/or H3 haplotype of L-SIGN were
bout 3.6 times more at risk for intrauterine transmission of HIV-1
nd 5.7 times at risk for intrapartum transmission. The H1 and H3
aplotypes are characterized by two single nucleotide polymor-
hisms in the promoter region (p-198A) and the intron 2 (int2-
80A) that associatewith a reduction of the transcriptional activity.
he same study also showed that infants homozygous for the H1
aplotype showed a more than fourfold decrease in the level of
lacental L-SIGN transcripts, and in particular of the membrane
inked isoforms [5].
A reduced expression of L-SIGN (especially of the membrane
soforms) in the endothelial cells of capillaries in the placenta may
acilitate the binding of HIV-1 to viral entry receptors of endothelial
ells, such as CCR5, which can facilitate the migration of maternal
IV-1 across the placental barrier, resulting in intrauterine trans-
ission of HIV-1 [5]. The membrane bound L-SIGN receptors are
esponsible for catching the virus. After capture, the virus adhered
o L-SIGN may undergo degradation processes or be presented as
ntigens. Thus, these receptors act to protect the infant against
nfection by HIV-1 [5]. Boily-Larouche et al. [5] explain these dis-
overies with the hypothesis that when the levels of placental
-SIGN-boundmembrane are reduced, virus fails to bind to L-SIGN
nd binds preferentially to CCR5 receptors on endothelial cells of
apillaries, resulting in loss of integrity of the placental barrier and
ncrease the passage of cells infected by HIV-1 in fetal circulation,
eading to vertical transmission.
. Concluding remarks and future directions
In view of what has been discussed, much evidence exist that
he DC-SIGN and L-SIGN receptors are involved in the transmission
f HIV-1 from mother to child. Therefore, the DC-SIGN and L-SIGN
eceptors should be likely targets for the development of new
rugs and antiretroviral therapies, to challenge the spread of viral
ransmission.
In addition to this, given that only a few genetic studies have
een performed to investigate the possible involvement of DC-
IGN and L-SIGN receptors in the genetic mechanisms correlated
ith vertical transmission of the HIV-1 virus, we believe that more
etailed studies aiming to elucidate the role of genetic variants
rom different worldwide populations in susceptibility and/or re-
istance to HIV-1 infection are needed.cknowledgments
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